1. Introduction
About 100 million years ago a whole genome duplication (WGD) in an ancestral yeast occurred, giving rise to
Saccharomyces. The mechanism behind this genome duplication was long under debate, with theories suggesting a mating event between closely related
Klyveromyces strains followed by genomic reorganization or independent local duplications [
1,
2]. More recent studies, based on the availability of full genome sequences and a search for signs of ancient gene duplications, favor the hypothesis of a duplication of the full genome followed by a massive loss of about 90% of duplicated genes [
3]. About 13% of yeast proteins are encoded by paralogous genes, including pairs of transcription factors, protein kinases, myosins, cyclins and pheromones [
4].
Gene duplication generally is seen as an important source of evolutionary novelty. The idea is that after duplication one gene copy is free to diverge either to specify on only a part of the original functions (subfunctionalization), develop new functions (neofunctionalization) or gain positive effects by using pre-existing functions in a new context (exaptation). In theory, gene duplication and the persistence of the duplicated genes is related to functional innovations, otherwise the gene duplication is considered to be only a burden without benefit. Nevertheless, for about 70% of the 457 duplicated gene pairs, no strong divergence from the proposed ancestor
Klyveromyces waltii was found [
3]. In these cases, divergence may occur in regulatory regions or the duplication may simply increase gene dosage. The ability of
Saccharomyces cerevisiae to perform anaerobic fermentation, a biochemical pathway central to brewing and biofuel production, is believed to have originated as an adaptation following WGD [
5].
In our study, we focus on cell cycle regulation, and investigate five pairs of paralogous genes involved in this process:
CLN1/CLN2,
CLB1/CLB2,
CLB3/CLB4,
CLB5/CLB6, as well as
ACE2/SWI5 (
Figure 1). While these paralogous pairs are typically considered in conceptual and computational models [
6,
7,
8] as a single entity, they may have distinct roles. The B-type cyclins
CLB1 and
CLB2 regulate the transition from the G2 phase to mitosis. However,
CLB2 mRNA is enriched in the bud, where it could function as a sensor for bud size and readiness for the M-phase transition, while
CLB1 lacks this enrichment [
9]. This suggests that these two cyclins may have complementary but non-identical roles in mitotic regulation. Similarly,
CLN1 and
CLN2, although highly similar, show functional differences, particularly with regard to subcellular localization and their roles in promoting cell cycle progression [
9,
10]. The paralogues
ACE2 and
SWI5 are expressed at the M/G1 phase boundary with partly different roles. The transcription factor Ace2p is required for septum destruction after cytokinesis and it regulates transcription of genes involved in polarity and morphogenesis, while Swi5p activates transcription of genes required for mating type switching (HO endonuclease gene) and the mitotic exit by activation of
SIC1 transcription [
11]. There are some paralogue pairs where evolutionary divergence from the ancestor is happening only in one gene, while the other one stays mostly unaltered. For the majority of paralogues and also for our targets in this study this is not the case. The paralogue pair
CLB1/CLB2, for example, has protein identity to the
K. waltii ancestor of 59% and 63%, respectively. The lowest identity to the ancestor for the targets in our study was found for the transcription factors
ACE2/SWI5, with protein identities of 35% and 31%, respectively [
3]. The protein identity between
ACE2 and
SWI5 is the lowest in our target set at 46.84%, though not significantly lower than that of the cyclins. Interestingly coding sequence identity between
ACE2 and
SWI5 is with 70.12% much higher. Information about target genes and identity between paralogues is displayed in
Table 1.
Genetic robustness allows cells to maintain functionality despite perturbations and gene duplication plays a major role in this process. If one paralogue is deleted or inactivated, the other may compensate by increasing its expression, a mechanism known as genetic compensation. However, the frequency of genetic compensation and the underlying molecular mechanisms are still not fully understood [
12]. Earlier studies suggested that genetic compensation has only a minor role in genetic robustness [
13], but other findings challenge this view. Kafri et al. [
14] systematically analyzed paralogous compensation in yeast and found that it occurs mainly between paralogues with different expression profiles, pointing to regulatory reprogramming. More recently, Vande Zande et al. [
15] showed that the yeast paralogue
TDH2 is actively upregulated when
TDH3 is deleted, mediated by transcriptional regulators. DeLuna et al. [
16] showed that in 10% of cases, this increased transcript level translates into higher protein abundance, which is essential for functional compensation.
In this study, we used single-molecule inexpensive fluorescence in situ hybridization (smiFISH) [
17] to investigate the expression profiles of
CLB1/CLB2,
CLB3/CLB4,
CLB5/CLB6,
CLN1/CLN2 and
SWI5/ACE2 (
Figure 1). According to Tsanov et al., it holds that “because of the low cost of the unlabelled primary probes, more probes per gene can be used, thus resulting in a substantial increase in signal quality”.
Figure 1A gives a schematic view on yeast cell cycle and
Figure 1B introduces the smiFISH principle. To explore the role of genetic compensation, we used deletion strains of the respective paralogues and analyzed their expression patterns. Additionally, we developed a convolutional neural network (CNN) to classify cells into specific cell cycle phases, with the classification criteria symbolized in
Figure 1C. The full series of steps taken is shown in
Figure 1D. We found distinct expression dynamics across paralogues, with differences in their regulation and cell cycle timing. Notably, we observed genetic compensation in some paralogues upon gene deletion, while others show little to no compensatory response.
Figure 1E shows an example of images employed for the analysis both for WT cells and for
clb2Δ strains.
3. Results
To investigate differences in the mRNA expression of key cell cycle regulators, we measured absolute transcript numbers for CLB1, CLB2, CLB3, CLB4, CLB5, CLB6, CLN1, CLN2, ACE2, SWI5 and SIC1 using smiFISH.
3.1. Distinct mRNA Expression Patterns of Cell Cycle Regulators
Analysis of mRNA distributions revealed varied expression patterns across the genes studied (
Figure 3). The boxenplots illustrate mRNA detection across the entire cell population coming from three to five replicate experiments, highlighting the variability in expression levels. Results from the individual experiments can be found in
Figure S2. Notably,
CLN1 and
CLN2 showed the highest overall expression, with mean values of 1.68 and 1.89 spots per cell, respectively. In contrast,
CLB4 emerged as the least detected gene, with a mean value of 0.59 spots per cell. This variation highlights the diverse expression patterns among the genes. It had been suggested that gene expression can occur in two primary modes: continuous (constitutive) expression, where transcripts accumulate steadily over time, or bursty expression, where transcription happens in short, intense pulses [
23]. Most of the regulators exhibited intense transcriptional bursts with some cells containing up to 52 transcripts for
CLN2, while
CLB3 and
CLB4 displayed lower overall expression with less pronounced peaks of about 10 transcripts, suggesting an expression pattern with less intense bursts, closer to a constitutive rather than bursty expression. The histograms further elucidate the distribution of mRNA levels among individual cells.
CLB1 and
CLB2,
CLB4,
CLB5,
CLB6, were all detected in between 38% to 32% of the cells. Interestingly, the paralogue pair with the lowest expression levels (
CLB3/CLB4) had the highest proportion of cells without detectable spots, with 60% and 42% of cells showing no signal, respectively. These findings could suggest the hypothesis of a more constitutive expression pattern, characterized by lower but more widely distributed detection of spots across the entire cell population, though the very low numbers of measured mRNA molecules don’t allow for strong conclusion. Furthermore, despite their significantly higher mean expression levels,
CLN1 and
CLN2 were only detected in approximately 40% of the cells. These findings suggest that while
CLN1 and
CLN2 exhibit intense transcriptional bursts in individual cells, their activity may be more phase specific.
3.2. Correlation Analysis Reveals Co-Expression or Distinct Regulation of Paralogous Gene Pairs
To explore relationships between the expression levels of paralogous genes, we calculated the mean single-cell Pearson correlation coefficient (
Table 2). The values reveal that
CLB1/CLB2,
CLB5/CLB6, and
SWI5/ACE2 exhibit moderate positive correlations, with values around 0.5, suggesting co-regulation. The
CLN1/CLN2 pair showed the highest correlation coefficient, with a value of 0.68. In contrast,
CLB3/CLB4 displayed weak correlation, with a value of 0.26, highlighting distinct expression patterns. These findings suggest divergent co-expression patterns and underlying regulatory mechanisms for paralogue genes within the cell cycle.
In addition to examining correlations among paralogous genes, we investigated the relationship between each gene’s expression and the expression of
SIC1, a key cell cycle regulator. The correlation values (
Tables S1 and S2) revealed that all the genes included in this study showed minimal correlation with
SIC1, reflecting either distinct regulatory mechanisms that may function independently of
SIC1 throughout the cell cycle or simply a clear temporal delay between their expression.
3.3. Phase-Specific Expression Patterns of Paralogous Genes Across the Cell Cycle
To examine gene expression throughout the cell cycle, we first combined smiFISH detection with spindle pole body (SPB) recognition, see
Figure 1E. SPB visualization was achieved by tagging Spc42p with mTurquoise as explained in Materials and Methods and the
Supplementary Materials. Cells with one SPB correspond mainly to G1, S, and M phases, cells with two SPBs only account for G2 phase, and cells with zero SPB are mostly S/Buds or G2/Buds [
19]. The analysis (
Figure S3) reveals distinct expression patterns for specific paralogues across the cell cycle.
CLB1/CLB2 are predominantly expressed in cells with two SPB, suggesting peak transcription during G2 phase. In contrast, the
CLN1/CLN2 pair shows higher mean values for cells with 1 SPB, suggesting stronger transcriptional activity during G1, S or M phases. These findings highlight phase-specific regulation of paralogous genes, with distinct transcriptional activity associated with different cell cycle stages.
To achieve a higher resolved assessment of cell-cycle stage specific expression we trained and employed a CNN for automatic cell-cycle assignment of cells. The resulting analysis supports the previous finding of phase specific regulation patterns, with higher expression for
CLB1 and
CLB2 in G2 mothers, while it also shows the distinct transcriptional activity in the G2 Buds (
Figure 4). The cell-cycle specific mRNA expression of all analyzed genes can be found in
Supplementary Figures S4 and S5. For most of the genes analyzed here, the expression pattern fitted quite well to previously published data [
24,
25]. In their studies, expression peaks in G1 phase were found for
CLB5/CLB6 and
CLN1/CLN2, expression in S-G2 for
CLB3/CLB4, expression in G2 for
CLB1/CLB2 and in G2-M
ACE2/SWI5. For
CLB1/CLB2,
CLB3/CLB4 and
ACE2/SWI5, our data confirm the expression pattern published. For
CLB5/CLB6, we see only very low transcript numbers and no clear peak phase as well as for
CLN1/CLN2 even though transcript numbers for the latter are higher.
3.4. Distinct Localization of CLB1 and CLB2: CLB2 Is Enriched in the Bud
The localization of CLB1 and CLB2 shows distinct patterns throughout the cell cycle. Both genes have expression peaks in G2 phase but their subcellular distributions are different. CLB1 has a higher expression level than CLB2 and is mainly localized to the mother cell, while CLB2 is found in both the mother cell and the bud, suggesting a functional specialization, with CLB2 likely involved in processes in the bud during the G2 phase.
She2p is a RNA-binding protein and part of She2p-She3p mRNA transport complex that brings certain proteins to the bud. She2p was shown to be involved in transport of
CLB2 mRNA to the bud [
26] but not
CLB1. Since we saw difference in compensation between the
clb1Δ and the
clb2Δ strain, we went on to check their expression pattern in the
she2Δ strain (
Figure 5). We see that
CLB1 is massively upregulated in the mother cell, but only slightly in the bud.
CLB2 in the mother is even more upregulated, with a few spots in the bud. We speculate that the upregulation in the mother leads to higher density leading to a diffusion of mRNAs into the bud, even without support from She2.
3.5. Genetic Compensation in Deletion Strains
To investigate the potential genetic compensation between paralogues, we compared mRNA expression levels between WT and deletion strains, where each gene was examined in the context of its paralogue’s deletion. The relative frequency of mRNA detections for each gene in the WT and the paralogue deletion was analyzed, as shown in
Figure 6. The cell cycle resolved violin plots, seen in
Figure 7 and in the
Figures S6 and S7, visualize the distribution of mRNA counts across different cell cycle phases. The analysis of mRNA distributions showed significant differences in expression between WT and deletion strains for most genes, with a decrease in the frequency of cells with zero detected transcripts in deletion strains, suggesting compensatory upregulation.
In the clb2Δ strains, the proportion of cells without detectable CLB1 mRNA decreased from 68% (WT) to 27%, with some cells in the mutant exhibiting transcriptional bursts with up to 31 detected CLB1 spots, compared to WT. All phases showed a noticeable increase in CLB1 expression, with more cells shifting toward higher transcript counts compared to WT. Especially the S and G2 phase exhibited a clear increase in CLB1 expression, pointing to transcriptional compensation. In the clb1Δ strains, the proportion of cells without detectable CLB2 mRNA decreased from 62% in the WT to 41% in the clb1Δ strains, with some cells in the mutant showing up to 23 detected CLB2 spots. Notably, a greater number of spots were detected in the G2-budded phase of the mutant, suggesting increased transcriptional activity in this specific cell cycle stage.
Similarly, the CLB3/CLB4 pair exhibited transcriptional compensation. The CLB3 detection in the WT and clb4Δ mutant revealed that the proportion of cells without detectable CLB3 mRNA (0 spots) was lower in the clb4Δ strain compared to the WT, consistent with compensatory upregulation. Similarly, the proportion of cells showing only one detectable CLB3 spot was also reduced in the clb4Δ strain. Instead, a greater fraction of cells in the clb4Δ mutant exhibited two or more CLB3 spots, with some cells showing up to 17 spots, and rare outliers reaching 23 spots. This suggests a redistribution of CLB3 expression, with fewer cells displaying low expression levels (0–1 spots) and more cells exhibiting moderate to high expression levels (2+ spots). The upregulation of CLB3 in the clb4Δ strain was observed across all cell cycle phases. The CLB4 detection in the WT and clb3Δ deletion strains showed a trend consistent with compensatory upregulation, with fewer cells lacking detectable CLB4 mRNA in the clb3Δ strain compared to WT. A slight increase in the fraction of cells with multiple CLB4 spots was observed, with some cells showing up to 13 spots. However, unlike the clb4Δ mutant, the shift toward higher expression levels in the clb3Δ strain was less pronounced, and fewer cells exhibited high numbers of CLB4 spots, suggesting weaker compensatory upregulation and limited transcriptional bursting. Additionally, no phase-specific upregulation was observed for CLB4 in the clb3Δ strain.
In contrast, CLB5/CLB6 showed little to no transcriptional compensation. No strong compensatory upregulation was observed in either deletion mutant. In the clb6Δ strain, the proportion of cells without detectable CLB5 mRNA remained stable at around 60%, with no major shifts in expression across cell cycle phases. In the clb5Δ strain, the proportion of cells without detectable CLB6 mRNA increased from 68% in WT to 76%, and the fraction of cells with moderate-to-high CLB6 expression (2+ spots) was lower than in WT, dropping by more than half. Rather than showing signs of compensatory upregulation, CLB6 expression was further reduced in the absence of CLB5. This pattern contrasts with other cases of transcriptional compensation, such as CLB1/CLB2 and CLN1/CLN2, where deletion of one gene led to a clear increase in expression of the other. Instead, these results suggest that CLB5 and CLB6 do not engage in meaningful compensatory regulation at the transcriptional level.
Both CLN1 and CLN2 exhibited inherently bursty transcription in our data, characterized by sporadic but high-magnitude transcriptional events. This pattern was observed in both WT and deletion strains, with some cells exhibiting exceptionally high transcript counts. For CLN1, the proportion of cells without detectable CLN1 mRNA decreased from 60% in WT to approximately 33% in the cln2Δ strain. The mutant also exhibited a greater fraction of cells with high transcript counts, indicating more frequent transcriptional bursts compared to WT. In the cln2Δ mutant, cells showed up to 44 detected CLN1 spots, although rare outliers with even higher counts (up to 52 spots) were observed. Upregulation was seen across all phases, with a slightly stronger increase during late M phase, suggesting a phase-dependent compensatory response. However, in the cln1Δ strain, the proportion of cells without detectable CLN2 mRNA did not decrease but instead slightly increased, from 58% in WT to 62% in the mutant, suggesting no strong, widespread compensatory upregulation at the population level. While rare transcriptional bursts reaching up to 59 detected spots were observed in individual cells, these appeared as isolated events rather than a general shift toward higher expression. Notably, the p-values of the Mann-Whitney U test indicate that CLN2 has the highest p-value () among the tested pairs, despite still being extremely small. Given the high number of analyzed cells, even such differences in p-values may suggest varying degrees of transcriptional divergence. While all tested gene pairs show highly significant differences, some exhibit even stronger shifts in expression patterns than others.
Unlike CLN1 in cln2Δ, where a clear increase in high-expression cells was seen, the response of CLN2 in cln1Δ suggests an asymmetrical compensation dynamic, where deletion of CLN2 induces a stronger compensatory response in CLN1 than vice versa. Additionally, no phase-specific regulation was observed for CLN2 in the cln1Δ strain, reinforcing the idea that its compensatory potential might be more constrained or subject to additional regulatory mechanisms. Both CLN1 and CLN2 displayed bursty transcriptional behavior, with sporadic but pronounced increases in transcript counts. This suggests their regulation may involve stochastic transcriptional pulses, enhanced under compensatory conditions.
SWI5 showed little to no evidence of genetic compensation upon deletion of ACE2, aside from a slight increase in transcription counts during the S phase in the mutant, which was minimal and does not indicate meaningful compensatory upregulation. However, we were unable to perform the corresponding experiments for the deletion of SWI5, preventing us from assessing whether ACE2 could compensate in its absence due to the low number of detected mRNA molecules, making it difficult to distinguish from background noise.
Boxenplots in the
Figures S8 and S9 summarize the central tendency of mRNA expression levels for the WT and the deletion strains. For
clb2Δ strains, the mean mRNA count for
CLB1 increased from 0.8 in WT to 3.8 in deletion, while in
clb1Δ strains, the mean mRNA count for
CLB2 increased from 0.7 in WT to 1.3 in deletion. Across some of the other paralogue pairs, a general pattern of compensatory upregulation was evident, with notable increases in mean transcript counts for one paralogue when its partner was deleted. This trend was particularly pronounced in pairs such as
CLB3/CLB4 and
CLN1/CLN2, where the deletion of one gene led to a redistribution of expression levels, shifting towards higher transcript counts for the remaining paralogue.
Table 3 presents the summary of the results.
3.6. Phenotype of Deletion Strains
We used the cell segmentation from Cellpose 3.0 also as a measure of cell size and for comparison of the deletion strains with the WT strain. Most of the B-Cvclin deletions lead to bigger cells, while
clb1Δ and
clb3Δ show smaller cells (
Figures S10–S12). Deletions of
cln1Δ and
cln2Δ show less significant size effects, with only a moderate increase for
cln2Δ, while
swi5Δ and
ace2Δ have no influence on cell size. Deletion of
she2Δ leads to a slight increase in cell size. We also measured doubling time by absorbance recording of the strains used in 96 well plates in YPD medium. Recording was performed every 30 min and results were fitted with an exponential function. From the exponent giving the generation time, doubling time was calculated by dividing ln2 with generation time. Mean doubling times are shown in
Supplementary Figure S13. Besides the
sic1Δ deletion, the other strains used show no significant growth delay.
4. Discussion
In this study, we have investigated several thousand single cells per experiment in order to shed light on the differential expression of a set of paralogous yeast cell cycle genes, which are often treated like being the same. To this end, we used single-molecule inexpensive fluorescence in situ hybridization (smiFISH) and counted always groups of three types of single mRNA molecules per cell. We found differences in the expression of the paralogues, but we also found different characteristics between the pairs. While CLB3/CLB4 exhibits a difference in expression, CLB1/CLB2 shows a difference in their localization (enrichment of CLB2 in the bud), CLN1 reacts with an up-regulation, differently to the deletion of its counterpart than CLN2.
While our study observed these effects, not all of them can be explained by our findings and would require alternative experimental approaches. Here, we can conclude the following: While
CLN1 and
CLN2 are very similar and share many regulatory mechanisms, there are some subtle differences in their expression regulation, with higher number of observations for
CLN2. Their similarities comprise that (i) Both
CLN1 and
CLN2 are activated by the transcription factors SBF and MBF, which bind to SCB and MCB elements in their promoters, respectively. This shared regulation ensures their coordinated expression during late G1, (ii) both
CLN1 and
CLN2 are positively regulated by Cln3p, which contributes to their transcriptional activation. (iii) Both
CLN1 and
CLN2 are negatively regulated by G2 cyclins (Clb1p, Clb2p, Clb3p, Clb4p), ensuring their repression during G2 phase [
27], and eventually (iv) both
CLN1 and
CLN2 are targets of Far1p, which inhibits their activity in response to pheromone signaling [
28]. Their differences are first quantitative differences: While both
CLN1 and
CLN2 are expressed in late G1 [
25], we found subtle quantitative differences in their expression levels. Studies suggest that
CLN1 might be more sensitive to changes in carbon sources and play a more significant role in adapting cell size to nutrient availability [
29]. Although both Cln1p and Cln2p proteins are distributed between the nucleus and cytoplasm, Cln1p shows a stronger nuclear accumulation compared to Cln2p. This difference in localization might lead to subtle variations in their interactions with other proteins and their downstream effects. While they have overlapping functions, they might have slightly different specific roles in cell cycle progression. For example,
CLN1 has been implicated in pseudohyphal development, a filamentous growth form in yeast, while
CLN2 might have a more prominent role in other aspects of cell cycle control [
30]. In our study we see a slight expression peak for
CLN1 and
CLN2 in S phase, but have to be aware that the discrimination of late G1 from S phase is not perfect. The oscillatory behavior in our study is probably blurred by the inaccuracy of phase assignment. We see a clear overrepresentation of G1 phase and an underrepresentation of S phase in all experiments. S phase assignment is complicated by the fact, that small buds are often not segmented by Cellpose 3.0.
CLB5 and
CLB6 are a pair of B-type cyclins crucial for the initiation of DNA replication during the S phase of the cell cycle [
31]. They share many similarities in their regulation, but also exhibit some key differences. Among the similarities are that both
CLB5 and
CLB6 are primarily activated by the transcription factor complex MBF (Mbp1p/Swi6p). MBF binds to MCB elements in the promoters of both genes, driving their expression during late G1 phase, just before the onset of S phase. Their coordinated expression ensures the availability of these cyclins when needed for DNA replication. Both Clb5p and Clb6p, when bound to Cdc28p (a cyclin-dependent kinase), form active complexes that are essential for initiating DNA replication. They contribute to the phosphorylation and activation of proteins involved in the assembly of the pre-replicative complex (pre-RC) at replication origins. Their differences are first slight quantitative differences: While both cyclins are expressed in late G1, there might be subtle quantitative differences in their expression levels. Studies suggest that Clb5p might be more abundant than Clb6p, implying potential differences in their contributions to DNA replication [
32]. While MBF is the primary activator, other factors might influence the expression of
CLB5 and
CLB6 to varying degrees. For example, some evidence suggests that Cln1p and Cln2p, the G1 cyclins, might also play a role in the activation of
CLB5 and
CLB6 transcription, though the precise mechanisms are not fully understood [
33]. While they both Clb5p and Clb6p contribute to DNA replication initiation, they might have slightly different specific roles in the process. For instance, some studies suggest that Clb5p might be more important for the initiation of replication at specific origins, while Clb6p might play a more general role in ensuring the overall progression of S phase [
34,
35]. In our study we found lower mRNA numbers for
CLB5 and
CLB6 in respect to other B-cyclins and no strong oscillatory behavior. Deletion strains of
clb5Δ and
clb6Δ develop bigger cells and
clb5Δ has a small growth delay in respect to WT (see
Supplementary Materials).
CLB5 and
CLB6 show no evidence of transcriptional compensation upon deletion of their respective paralogue.
B-type cyclins
CLB3 and
CLB4 play important roles in the G2/M transition of the cell cycle. They are mainly expressed during S phase and G2, with their mRNA and protein levels peaking in G2, just before the onset of mitosis. This coordinated expression ensures their availability for the G2/M transition [
25]. Both Clb3p and Clb4p, when bound to Cdc28p, form active complexes that are essential for promoting the G2/M transition. They contribute to the phosphorylation and activation of proteins involved in mitotic spindle assembly and other processes required for cell division. Unfortunately, the precise upstream regulators of
CLB3 and
CLB4 are not as well-defined as those for
CLB5/CLB6, but they are likely influenced by upstream activators and repressors that coordinate their expression with the cell cycle progression. For the protein level, studies suggest quantitative differences, i.e., that Clb3p might be more abundant than Clb4p, implying potential differences in their contributions to the G2/M transition [
36]. This difference in abundance is confirmed by our expression data, we also see lower numbers for
CLB4 mRNA than for
CLB3. Although both contribute to the G2/M transition,
CLB3 and
CLB4 might have slightly different specific roles in the process. For instance, some studies suggest that Clb3p might be more important for certain aspects of spindle assembly, while Clb4p might play a more prominent role in other mitotic events [
37]. Genetic studies have revealed some differences in the interactions of
CLB3 and
CLB4 with other genes. These differences might reflect subtle variations in their functions and their contributions to different cellular pathways [
33].
CLB1 and
CLB2 are another–final–pair of B-type cyclins crucial for the G2/M transition, which is the point in the cell cycle where the cell prepares to divide. Both
CLB1 and CLB2 are known to be expressed during the S and G2 phases of the cell cycle, with their levels peaking in G2, right before the cell enters mitosis (M phase) [
25]. This coordinated timing ensures that these proteins are available when needed for cell division. Both Clb1p and Clb2p, when they bind to Cdc28p (a cyclin-dependent kinase), form active complexes that are essential for promoting the G2/M transition [
38]. They help to activate proteins involved in mitotic spindle assembly and other processes necessary for cell division. Both Clb1 and Clb2 proteins are degraded at the end of mitosis. This degradation is crucial for the proper progression of the cell cycle and prevents premature entry into the next cell cycle. While both cyclins are expressed in S and G2, there might be subtle differences in the amount of each protein produced. Studies suggest that Clb2p is generally more abundant than Clb1p, implying that Clb2p might play a more dominant role in mitosis. Although they both contribute to the G2/M transition,
CLB1 and
CLB2 might have slightly different specific roles in the process. For instance, some research indicates that Clb1p might be more important for meiosis (cell division for sexual reproduction), while Clb2p is more crucial for mitosis (cell division for growth and repair) [
39]. While the exact upstream regulators of
CLB1 and
CLB2 are still being studied, it’s likely that they are influenced by other factors that coordinate their expression with the cell cycle. For example, some studies suggest that the RNA-binding protein Puf5p and the HMGB protein Ixr1p might play a role in regulating
CLB1 expression [
40]. Our smiFISH gene expression analysis revealed the clearest oscillation for
CLB1/
CLB2 among the analyzed paralogues. Both peak in G2 phase with
CLB1/having the higher total abundance, while
CLB2 is enriched in the bud. For
CLB2 a She2p-She3p dependent mRNA transport was shown [
26], why we analyzed the pair as well in the
she2Δ background, were active transport should be abolished. We see for both
CLB1 and
CLB2 compensation for the paralogue and we see also for both up-regulation in the
she2Δ background. Interestingly the up-regulation is mainly visible in the mother cells, while the mRNA numbers in the bud stay unchanged, why we speculate, that expression is turned on until a level, where enough mRNA enter the bud by simple diffusion or in other words, until the bud is satisfied. Surprisingly, this is the case for both species. Whether this means, that there is also
CLB1 transport to the bud, we can not rule out.
ACE2 and
SWI5 are two homologous transcription factors that play crucial roles in the late stages of mitosis and early G1 phase, particularly in daughter cell development [
25]. Both Ace2p and Swi5p possess highly conserved zinc finger DNA-binding domains, enabling them to recognize and bind to the same DNA sequences in the promoters of their target genes. Both proteins are active in late mitosis and early G1, specifically in daughter cells [
41]. Their activity is tightly regulated by their nuclear localization, which is controlled by phosphorylation events. And both Ace2p and Swi5p are involved in the transcriptional activation of genes required for daughter cell separation (septum degradation) and bud site selection. However, they also show important differences. Despite sharing similar DNA-binding domains, Ace2p and Swi5p regulate distinct sets of genes [
42]. Ace2p primarily activates genes involved in septum degradation (e.g., CTS1, SCW11) and bud site selection (e.g., BUD9), while Swi5p regulates genes with different functions [
43]. Ace2p, but not Swi5p, represses the transcription of
CLN3, a G1 cyclin [
44]. This repression contributes to the longer G1 phase observed in daughter cells compared to mother cells, allowing them to grow sufficiently before budding. While both proteins are nuclear during their active phase, their nuclear localization is differentially regulated. Ace2p’s nuclear entry and exit are controlled by phosphorylation events mediated by Cbk1p, which specifically targets daughter cells. Swi5p’s localization might be regulated by different mechanisms [
45]. Although both contribute to cell separation, they might have slightly different roles. Ace2p is essential for the degradation of the septum between mother and daughter cells, while Swi5p might be involved in other aspects of cell separation or daughter cell development. For
ACE2 and
SWI5 our expression data differ to previously reported results. Rather than the expected expression in late mitosis/G1, we observe peak expression in G2. Whether this results from a time delay between transcription and translation remains uncertain. Interestingly, we see no compensation of
SWI5 for
ace2Δ.
In addition to gene expression changes, we also observed differences in cell size in certain deletion mutants. Normalized cell area distributions (
Figures S10–S12) revealed that
clb1 and
clb3 mutants exhibited smaller cell sizes compared to WT, whereas
clb2 and
clb4 mutants showed size distributions similar to WT. Additionally,
clb6 cells appeared slightly larger, a trend also visible in microscopy images. The remaining deletion strains displayed no notable deviations in cell size.
Other publications focusing on FISH data are analyzing next to mature mRNA also transcription sites (e.g., [
46]). Our targets are very low expressed and we see transcription sites not regularly, even in bursts they are mostly not seen, why we did not include transcription site analysis.
Compared to other studies that synchronized yeast cell cycle by adding
-factor (e.g., [
47]), we used asynchronous cell populations in order to least perturb the expression and cell growth during different cell cycle phases.
Taken together, the oscillation behavior of most of our targets corresponds to literature. The mean values per phase are potentially slightly too low in the peaks and too high in G1 due to imperfect phase assignment. The reason is that in our cell cycle phase assignment model the number of G1 phase cells is always overestimated and the number of cells in S phase is underestimated, because (i) the small bud is sometimes not seen and (ii) also the spindle pole body, which separates budding cells between S phase (1 SPB) and G2 (2 SPB), is in quite a number of cases not visible, which also may lead to wrong assignment.
Our data gives also rise to reason about whether expression of the considered genes is more steady or more burst-like, though without mechanistic explanation. The low number of peaks of both
CLB3 and
CLB4 together with their low number of cells without any peak would be more supportive of a continuous basal expression, while high peaks and many cells without any peak seem to point to more burst-like expression of
CLN1 and
CLN2. Here, we should also take into account half-life times, which have been reported as 5.03 min for
SIC1, 5.98 min for
CLN1, 7.43 min for
CLN2, 7.45 min for
CLB1, 4.95 min for
CLB3, 3.76 min for
CLB4, 6.12 min for
CLB5, 4.84 min for
CLB6, 6.6 min for
CDC28, 7.49 for
SWI5 and finally 5.74 min for
ACE2 [
48]. This means, that mRNA molecules of
CLN2 and
CLB1 would have a higher probability of being detected once expressed than mRNA molecules of
CLB3 or
CLB4, which are faster degraded.